Disclosures for "Unique Quality of Life Priorities for People with Epilepsy and Comorbid Non-epileptic spells"
-
Ms. Cui has nothing to disclose.
-
Mr. Moss has stock in Seizure Tracker LLC. Mr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as a partial owner of Seizure Tracker LLC with Neuropace. Mr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as a partial owner of Seizure Tracker LLC with Epitel. Mr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as a partial owner of Seizure Tracker LLC with TSC Alliance. Mr. Moss has received personal compensation in the range of $50,000-$99,999 for serving as a partial owner of Seizure Tracker LLC with UCB.
-
Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precisis GmbH. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iVEAcare. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace, Inc.. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has stock in Novela Neurotechnologies. Dr. Rao has stock in EnlitenAI. Dr. Rao has stock in Doximity, Inc. Dr. Rao has stock in Theta Neurotech. Dr. Rao has stock in Encephalogix.
-
Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .